|Articles|January 1, 2020
- BioPharm International-01-01-2020
- Volume 33
- Issue 1
BioPharm International, January 2020 Issue (PDF)
Click the title above to open the BioPharm International January 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Faster, Better Bioprocessing in 2020almost 6 years ago
Can Policy Keep Pace with Science and Discoveries?almost 6 years ago
Mapping a Route for Cell and Gene Therapy Process Developmentalmost 6 years ago
Choices for Climbing the Biopharma Career Ladderalmost 6 years ago
Pharma Regulation to be Shaped by Pricing and Production Issuesalmost 6 years ago
Lyophilization Presents Complex Challengesalmost 6 years ago
Single-Use Bioreactors: To Scale Up or Scale Out?almost 6 years ago
Therapeutic Potential of Green, Synthesized Gold Nanoparticlesalmost 6 years ago
Getting to the Root of Quality ProblemsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
